“Global Insight Services offers unparalleled market intelligence and strategic consulting services”. to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition.
The global sepsis diagnostics market was valued at USD 503.4 million in 2021 and it is anticipated to grow up to USD 1181.5 million by 2031, at a CAGR of 8.9% during the forecast period.
Sepsis is a potentially fatal illness that arises when the body’s immune system attacks its own tissues in reaction to an infection. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally. Septic shock can develop from sepsis. This is a sudden reduction in blood pressure that can cause serious organ damage and even death. Treatment with antibiotics and intravenous fluids as soon as possible enhances the chances of survival.
Unlock Growth Potential in Your Industry – Get Your Sample Report Now@https://www.globalinsightservices.com/request-sample/GIS10358
Market Trends and Drivers
Rising incidence of hospital-acquired infections will augment the market growth during the forecast period. Hospital-acquired infections (HAIs), also known as nosocomial infections, are a major cause of morbidity and mortality worldwide. The most common hospital-acquired infections (HAIs) are urinary tract infections, pneumonia, and sepsis. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses. In the U.S., the incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide, the demand for sepsis diagnostic products is also expected to rise in the coming years.
Market Restraints and Challenges
High cost of automated diagnostic devices may hamper the industry growth. The cost of molecular diagnostic tests is between USD 300 and USD 3,000, which is very high compared to the cost of blood culture tests, priced as low as ~USD 28–35. Companies focus on developing automated diagnostic devices based on advanced technologies, such as molecular diagnostics, on detecting sepsis but due to limited budgets, government hospitals (especially in emerging nations) and academic research laboratories cannot afford such systems. Further, becoming the major factor for the hindrance of the growth of sepsis diagnostics market.
Unlock Insights: Request Your Customizable Report Today@https://www.globalinsightservices.com/request-customization/GIS10358
Global Sepsis Diagnostics Market Segmentation
Product
- Instruments
- Blood Culture Media
- Assay Kits and Reagents
Technology
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Flow Cytometry
Pathogen
- Bacterial Sepsis
- Fungal Sepsis
- Others
Testing Type
- Laboratory Testing
- PoC Testing
End-use
- Hospitals and specialty clinics
- Pathology & Reference Laboratories
- Research Laboratories & Academic Institutes
Major Players in the Global Sepsis Diagnostics Market
The key players in the market are bioMérieux (France), Becton, Dickinson and Company (US), Danaher Corporation (US), T2 Biosystems (US), Luminex (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), Bruker Corporation (US) and Abbott Laboratories (US), among others.
Drive Your Growth Strategy: Purchase the Report for Key Insights@https://www.globalinsightservices.com/checkout/single_user/GIS10358
COVID-19 Impact
The COVID-19 pandemic had a moderately positive effect on the sales of diagnostics products for sepsis. The global spread of covid-19 and the emerging cases of sepsis among covid-19 patients are likely to increase the demand for rapid diagnosis, accelerating the utilization of instruments, reagents, & assay kits for detection of sepsis. Lockdowns resulting from the pandemic caused people to delay undergoing health checkups, affecting the number of tests performed and reagent sales. The current COVID-19 pandemic has highlighted the risk faced by older adults, who are more susceptible to complications, including acute respiratory distress syndrome, usually due to pneumonia, which increases the risk of developing sepsis. Thus, increasing the need for early diagnosis of sepsis among patients with covid-19 infections.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.